Zak Mir takes a charting look at some of the most closely followed small caps on the London Stock Exchange. Today’s charts are FTSE 100, DAX, Dow, Bitcoin, Ethereum, Gold, WTI
Traders Cafe with Zak Mir: Bulletin Board Heroes, Tuesday 21st April 2026
Zak Mir takes a charting look at some of the most closely followed small caps on the London Stock Exchange. Today’s charts are for the FTSE 100, DAX, Dow, Bitcoin, Ethereum,
RNS Hotlist with Zak Mir: BRES, RPI, TTA, SAAS, EGT, SOLG, ALTN, POLB, AREC, GENI & ZOO
The Telegraph: Co-op unveils £206m hit from cyber attack. IT shutdown led to data from retailers’ 6.5 million members being stolen
RNS Hotlist with Zak Mir: ACRM, ADT1, TTA, GGP, PANR, PRE, MDH, GRX, SAVE, MTL, KOD, DGE, PAT, BTC & CORA
Acuity (ACRM), the software group focused on cybersecurity announced a fundraising, comprising a Placing, Subscription and a Directors’ Intended Subscription to raise approximately £0.5 million. The net proceeds of the Fundraising
RNS Hotlist with Zak Mir: BZT, AJAX, PR1, TTA, BELL, GSCU, SVML, BEM, SML, JLP, DSCV, SVNS, HREE, MSMN, ORCP, BTRW, IXI, G4M & CRTA
The Telegraph: Inflation eased back last month, paving the way for interest rate cuts next month in a boost for Rachel Reeves. Prices, as measured by the consumer prices index (CPI),
RNS Hotlist with Zak Mir: OBI, VAST, LIFS, RMR, CBOX, DBOX, TTA, HVO, SVML, RPI, HUM, EGT, YU, MKA, UJO, MET1 & FCM
Ondine Biomedical (OBI), a Canadian life sciences company pioneering light-activated antimicrobial treatments, announced that it has agreed to a private placement financing in exchange for common shares from a new third-party
RNS Hotlist with Zak Mir: EUA, JOG, GOOD, EDX, TTA & SEEN
Eurasia Mining (EUA), the palladium, platinum, rhodium, iridium and gold mining company, announced that further to the announcements dated 27 June 2024, 29 July 2024 and 28 August 2024, its audit
RNS Hotlist with Zak Mir: ANA, AVCT, ORCP, SVML, EDX, LIFS, THX, ZPHR, FCM, GDLF, COBR & TTA
Ananda (AQSE:ANA), a clinical-stage life sciences company, shared promising results from recent preclinical studies investigating the efficacy of MRX1 (Patent Pending) in treating cardiac fibrosis and heart failure with preserved ejection